Evidence map›Paper›PMID 33046655›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Trapped topoisomerase II initiates formation of de novo duplications via the nonhomologous end-joining pathway in yeast.

Nicole Stantial, Anna Rogojina, Matthew Gilbertson, Yilun Sun, Hannah Miles, Samantha Shaltz, James Berger, Karin C Nitiss, Sue Jinks-Robertson, John L Nitiss

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. A multispecies toolkit ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Yeast Tools for Studying Type II Topoisomerases in Budding Yeast.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  7. Genome Instability Induced by Topoisomerase Misfunction.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Article
  10. Highly sensitive mapping ofbioRxiv : the preprint server for biology · 2024
    Article
  11. Article
  12. Article
  13. Naturally mutagenic sequence diversity in a human type II topoisomerase.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Recurrent mutations in topoisomerase IIα cause a previously undescribed mutator phenotype in human cancers.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Nicole StantialDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710.ORCID 0000-0002-2949-9955
Anna RogojinaPharmaceutical Sciences Department, University of Illinois at Chicago, Rockford, IL 61107.
Matthew GilbertsonPharmaceutical Sciences Department, University of Illinois at Chicago, Rockford, IL 61107.
Yilun SunPharmaceutical Sciences Department, University of Illinois at Chicago, Rockford, IL 61107.ORCID 0000-0002-6249-2704
Hannah MilesPharmaceutical Sciences Department, University of Illinois at Chicago, Rockford, IL 61107.ORCID 0000-0002-0952-552X
Samantha ShaltzDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710.
James BergerDepartment of Biophysics and Biophysical Chemistry, Johns Hopkins School of Medicine, Baltimore, MD 20215.ORCID 0000-0003-0666-1240
Karin C NitissPharmaceutical Sciences Department, University of Illinois at Chicago, Rockford, IL 61107.
Sue Jinks-RobertsonDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710; sue.robertson@duke.edu jlnitiss@uic.edu.ORCID 0000-0001-5924-5852
John L NitissPharmaceutical Sciences Department, University of Illinois at Chicago, Rockford, IL 61107; sue.robertson@duke.edu jlnitiss@uic.edu.
University of Illinois Chicago · USDuke Medical Center · USJohns Hopkins University · US

Funding

Structural and Biochemical Analyses of Type II DNA TopoisomerasesR01CA077373 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI BERGER, JAMES M. · 1999 to 2021
$7.6M
Regulation of mitotic genome stability in yeast.R35GM118077 · NIGMS · DUKE UNIVERSITY · PI JINKS-ROBERTSON, SUE · 2016 to 2023
$4.5M
Novel approaches for studying topoisomerase 2 targeting anti-cancer drugsR03CA216010 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NITISS, JOHN L · 2017 to 2018
$160k
NCI NIH HHS R01 CA077373NCI NIH HHS R03 CA216010NIGMS NIH HHS R35 GM118077
6 · The paper itself

Abstract

Topoisomerase II (Top2) is an essential enzyme that resolves catenanes between sister chromatids as well as supercoils associated with the over- or under-winding of duplex DNA. Top2 alters DNA topology by making a double-strand break (DSB) in DNA and passing an intact duplex through the break. Each component monomer of the Top2 homodimer nicks one of the DNA strands and forms a covalent phosphotyrosyl bond with the 5' end. Stabilization of this intermediate by chemotherapeutic drugs such as etoposide leads to persistent and potentially toxic DSBs. We describe the isolation of a yeast

Indexed as

DNA End-Joining RepairGene DuplicationDNA Topoisomerases, Type IIEtoposideRad52 DNA Repair and Recombination ProteinSaccharomyces cerevisiae ProteinsYeastsDNA Topoisomerases, Type IIEtoposideRad52 DNA Repair and Recombination ProteinRAD52 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsTOP2 protein, S cerevisiaeetoposidemutagenesisnonhomologous end joiningTop2yeast

Identifiers

PMID33046655
PMCPMC7604471
OpenAlexW3091885121

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.